医学
中国
内科学
胃肠病学
疾病
重症监护医学
原发性硬化性胆管炎
政治学
法学
作者
F C Zhang,L Wang,Zongwen Shuai,Zhenbiao Wu,Wentao Zhang,Z L Zhang,Jin Lin,Yun Zhao
标识
DOI:10.3760/cma.j.cn112138-20210520-00360
摘要
Primary biliary cholangitis is a chronic autoimmune cholestatic disease with a progressive course. This disease is not rare in China, but standardized diagnosis and treatment for primary biliary cholangitis are insufficient. Based on the evidence and guidelines from China and other countries, Rheumatology Branch of Chinese Medical Association developed the recommendations of diagnosis and treatment for primary biliary cholangitis in China. The aim is to help clinicians recognize clinical characters, therapeutic selection and prognosis judgement of primary biliary cholangitis, which will contribute to make diagnosis in time, to select treatment properly and to manage follow-up scientifically.
科研通智能强力驱动
Strongly Powered by AbleSci AI